相关实验视频

Updated: Jun 3, 2026

A Tailored HPLC Purification Protocol That Yields High-purity Amyloid Beta 42 and Amyloid Beta 40 Peptides, Capable of Oligomer Formation
06:34

A Tailored HPLC Purification Protocol That Yields High-purity Amyloid Beta 42 and Amyloid Beta 40 Peptides, Capable of Oligomer Formation

Published on: March 27, 2017

针对Aβ42诱导毒性的β-叶片配体的合理设计

Katrin Hochdörffer1, Julia März-Berberich, Luitgard Nagel-Steger

  • 1Universität Duisburg-Essen, Fachbereich Chemie, Universitätstrasse 5, 45117 Essen, Germany.

Journal of the American Chemical Society
|March 9, 2011
PubMed
概括

针对阿尔茨海默氏症的粉样β (Aβ) 纤维的新支架显示了双重的抗聚合效应. 脂友群稳定纤维,而充电的溶氨酸将其溶解成无毒材料.

更多相关视频

Selection of Aptamers for Amyloid β-Protein, the Causative Agent of Alzheimer's Disease15:23

Selection of Aptamers for Amyloid β-Protein, the Causative Agent of Alzheimer's Disease

Published on: May 13, 2010

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis06:17

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

Published on: May 22, 2018

相关概念视频

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...